title: The treatment of foveal central serous choroidopathy by krypton red laser.
abstract: We present 24 patients with recent foveal central serous choroidopathy. Only those in whom the leakage site was located within a radius of 250 microns from the foveal center were included in this study. All patients were treated with the krypton red laser (647 nm) within a week of the clinical diagnosis. At the end of the follow-up, 70.8% of the patients had a visual acuity of 6/8.5 or better, and an overall visual improvement was found in 83.3%. In 90% of the patients whose vision improved, significant absorption of subretinal fluid was seen within three weeks and in 10% within four weeks. No evidence of any macular pathology complicating the laser treatment was found at the end of the follow-up period of at least 36 months.
authors.affiliation: Dept. of Ophthalmology, Beilinson Medical Center, Petah Tiqva, Israel.
authors.forename: D
authors.initials: D
authors.lastname: Weinberger
authors.forename: I
authors.initials: I
authors.lastname: Kremer
authors.forename: I
authors.initials: I
authors.lastname: Ben Sira
mesh_terms: D000328:Adult; D015862:Choroid Diseases / Q000601:surgery*; D005260:Female; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D005584:Fovea Centralis / Q000601:surgery*; D005654:Fundus Oculi; D006801:Humans; D007726:Krypton; D053685:Laser Therapy / Q000009:adverse effects; D008266:Macula Lutea / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D012163:Retinal Detachment / Q000601:surgery*; D014792:Visual Acuity
chemical_list: D007726:Krypton